In tumor organoid-conditioned media, CAFs undergo a specific loss of myofibroblastic features but acquire phenotypes, including morphological activation, enhanced proliferation, and upregulated IL-6, IL-11, and leukemia inhibitory factor (LIF)43. The gene discussed is IL6; the disease is neoplasm.